Bulletin
Investor Alert

Europe Markets Archives | Email alerts

Nov. 11, 2019, 5:38 a.m. EST

Europe stocks sag on China trade and Hong Kong violence concerns

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    STOXX Europe 600 Index (SXXP)
  • X
    DAX (DAX)
  • X
    CAC 40 Index (PX1)

or Cancel Already have a watchlist? Log In

By Steve Goldstein, MarketWatch


Getty Images
The U.K. economy grew slower than forecast in the third quarter.

European stocks on Monday sagged on concerns over the progress of U.S.-China trade talks and violence in Hong Kong.

Having registered gains for five straight weeks, the Stoxx Europe 600 /zigman2/quotes/210599654/delayed XX:SXXP -0.26%  fell 0.22% to 404.52.

The German DAX /zigman2/quotes/210597999/delayed DX:DAX -0.27%  fell 0.2% to 13201.60, the French CAC 40 /zigman2/quotes/210597958/delayed FR:PX1 +0.18%   weakened 0.02% to 5888.41 and the U.K. FTSE 100 /zigman2/quotes/210598409/delayed UK:UKX -0.28%  declined 0.57% to 7317.44.

President Trump on Friday said he has not agreed to roll back China tariffs. Meanwhile, Hong Kong stocks plunged in wake of new violence there. Police shot an antigovernment protester on Monday, and a man was set on fire.

The U.K. reported slightly worse than forecast economic data, with GDP growing just 1% year-over-year in the third quarter, the worst rate of growth in more than nine years. The credit rating agency Moody’s on Friday night warned it could downgrade the U.K., citing concerns over a paralysis in policy-making and worries about spending plans.

Of stocks on the move, shares of Greggs /zigman2/quotes/205743109/delayed UK:GRG -0.38%  rallied 15% as the bakery chain reported same-store sales growth of 8.3% in the six weeks to Nov. 9 and increased its full-year pretax profit forecast.

Shares of Galapagos /zigman2/quotes/208057460/delayed NL:GLPG -0.99%   /zigman2/quotes/205153380/composite GLPG -0.19%  rose 3.4% as the pharmaceutical research firm and biotech company Gilead Sciences /zigman2/quotes/210293917/composite GILD +0.22%  say a rheumatoid arthritis drug, filgotinib, improved clinical outcomes versus placebo. Galapagos has most of the European rights to the drug and gets royalties outside Europe of at least 20%.

/zigman2/quotes/210599654/delayed
XX : STOXX
405.34
-1.05 -0.26%
Volume: 0.00
Dec. 10, 2019 5:50p
loading...
/zigman2/quotes/210597999/delayed
DAX
DX : Xetra Indices
13,070.72
-34.89 -0.27%
Volume: 80,063
Dec. 10, 2019 6:30p
loading...
/zigman2/quotes/210597958/delayed
FR : France: Euronext Paris
5,848.03
+10.78 +0.18%
Volume: 73,070
Dec. 10, 2019 6:05p
loading...
/zigman2/quotes/210598409/delayed
UK : FTSE UK
7,213.76
-20.14 -0.28%
Volume: 694,360
Dec. 10, 2019 4:59p
loading...
/zigman2/quotes/205743109/delayed
UK : U.K.: London
2,108.00 p
-8.00 -0.38%
Volume: 462,784
Dec. 10, 2019 4:35p
P/E Ratio
28.32
Dividend Yield
1.75%
Market Cap
£2.13 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/208057460/delayed
NL : Netherlands: Euronext Amsterdam
194.05
-1.95 -0.99%
Volume: 703,191
Dec. 11, 2019 3:00a
P/E Ratio
42.67
Dividend Yield
N/A
Market Cap
€12.67 billion
Rev. per Employee
€481,393
loading...
/zigman2/quotes/205153380/composite
US : U.S.: Nasdaq
$ 215.40
-0.42 -0.19%
Volume: 162,718
Dec. 10, 2019 4:00p
P/E Ratio
42.80
Dividend Yield
N/A
Market Cap
$13.37 billion
Rev. per Employee
$567,924
loading...
/zigman2/quotes/210293917/composite
US : U.S.: Nasdaq
$ 67.08
+0.15 +0.22%
Volume: 4.27M
Dec. 10, 2019 4:00p
P/E Ratio
32.03
Dividend Yield
3.76%
Market Cap
$84.68 billion
Rev. per Employee
$2.02M
loading...

Steve Goldstein is MarketWatch markets editor for Europe. Follow him on Twitter: @MKTWgoldstein.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.